87.5 F
San Fernando
Thursday, May 26, 2022

Acelyrin Appoints Chief Operating Officer

Melanie Gloria has been appointed as Acelyrin Inc.’s chief operating officer and will oversee the biopharmaceutical company’s business operations.

Acelyrin is based in Woodland Hills and develops therapeutics.

Gloria was the senior vice president of development operations at Horizon Therapeutics prior to joining Acleyrin. She is a former oncology nurse and has 20 years of experience in biotechnology developed through leading multiple research and development functions.

Gloria has also worked with and led teams at biopharma company AbbVie and medical device company Abbott Laboratories.

“Her business operations, health care, and leadership experience will benefit Acelyrin and our patients as we pursue our vision of bringing life-changing therapies to those with serious diseases,” Dr. Shao-Lee Lin, Acelyrin’s co-founder and chief executive, said in a statement.

The appointment comes not long after Acelyrin secured $250 million in Series B funding and a licensing agreement with Affibody AB in November.

Gloria has received multiple health care awards and serves on the board of Lake County Haven, a social service agency that helps homeless women and their children access independent living conditions.

“I am thrilled to join Acelyrin and this team of passionate colleagues as we work together to change patients’ lives with innovative drug therapies,” Gloria said in a statement.

Antonio Pequeño IV
Antonio Pequeño IV
Antonio “Tony” Pequeño IV is a reporter covering health care, finance and law for the San Fernando Valley Business Journal. He specializes in reporting on some of the biggest names in the Valley’s biotechnology sector. In addition to his work with the Business Journal, Tony has reported with BuzzFeed News on the unsupervised use of Clearview AI, a controversial facial recognition technology. Tony, who also conducts freelance reporting, graduated from the USC’s Master of Science in Journalism program in 2021. He is in his fifth year as a journalist as of 2021.

Featured Articles

Related Articles